Drugs / NVP-1705
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05141110 | Dec 2021 → Apr 2022 | — | NVP Healthcare | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NVP-1705 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05141110 ↗ |
| Route | Oral | “Tablet formulation for oral administration, single dose of NVP-1705 at Day 1” NCT05141110 ↗ |